{"gene":"LMF1","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2007,"finding":"LMF1 (encoded by Tmem112/Lmf1) is required for post-translational maturation of nascent lipoprotein lipase (LPL) and hepatic lipase (HL) polypeptides in the endoplasmic reticulum; loss-of-function mutations cause combined lipase deficiency and severe hypertriglyceridemia in mice and humans.","method":"Positional cloning of the cld mutation in mice, combined with identification of a homozygous deleterious human LMF1 mutation; biochemical measurement of LPL and HL activity","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis (cld mouse) combined with human mutation identification and biochemical lipase activity assays, replicated across multiple subsequent studies","pmids":["17994020"],"is_preprint":false},{"year":2009,"finding":"LMF1 is a polytopic ER membrane protein with five transmembrane domains, dividing the protein into six domains: three cytoplasmic (N-terminal domain, loops B and D) and three ER-luminal (loops A, C, and C-terminal domain). The evolutionarily conserved DUF1222 domain spans four of these six domains with the two largest portions facing the ER lumen. LMF1 physically interacts with LPL and hepatic lipase, and the lipase interaction site was mapped to loop C within DUF1222.","method":"Transmembrane topology mapping using ectopic glycan attachment site insertions and GFP terminal fusions; co-immunoprecipitation with naturally occurring DUF1222 truncation variants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — experimental topology mapping with multiple orthogonal tagging strategies plus direct physical interaction demonstrated by Co-IP with domain truncations, single lab","pmids":["19783858"],"is_preprint":false},{"year":2012,"finding":"Overexpression of Lmf1 in adipose tissue (aP2-Lmf1 transgenic mice) and muscle tissue (Mck-Lmf1 transgenic mice) increases LPL activity in vivo, establishing that variation in Lmf1 expression is a post-translational determinant of LPL activity beyond its role as a required maturation factor.","method":"Generation and characterization of aP2-Lmf1 and Mck-Lmf1 transgenic mice; measurement of LPL activity and LPL mass in relevant tissues","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean transgenic overexpression with tissue-specific LPL activity and mass measurements, two independent transgenic lines with distinct tissue outcomes","pmids":["22345169"],"is_preprint":false},{"year":2014,"finding":"LMF1 expression is induced by ER stress through the ATF6α arm of the unfolded protein response (UPR). ATF6α activates the Lmf1 promoter via a GC-rich cis-regulatory element 264 bp upstream of the transcriptional start site; ATF6α deficiency (genetic ablation or dominant-negative form) abolishes tunicamycin-stimulated Lmf1 promoter activation.","method":"Genetic deficiencies in mouse embryonic fibroblasts and mouse liver; luciferase reporter constructs with the Lmf1 promoter; tunicamycin treatment; dominant-negative ATF6α expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (genetic KO, dominant-negative, reporter assay, in vivo tunicamycin model) in single lab establishing ATF6α as both sufficient and necessary","pmids":["25035425"],"is_preprint":false},{"year":2014,"finding":"LMF1 is required for activation of endothelial lipase (EL) in addition to LPL and HL, demonstrating its role as a chaperone for multiple vascular lipases. LMF1-null mice are viable at birth (born at Mendelian ratios) but exhibit combined lipase deficiency, hypertriglyceridemia, and neonatal lethality.","method":"Generation and characterization of LMF1-null mice (null-allele knock-out); measurement of LPL, HL, and EL activity; qPCR and in situ hybridization","journal":"Nutrition & metabolism","confidence":"High","confidence_rationale":"Tier 2 / Moderate — null mouse model with direct biochemical measurements of multiple lipase activities, combined with expression analysis","pmids":["25302068"],"is_preprint":false},{"year":2018,"finding":"Specific LMF1 missense variants (p.Gly172Arg, p.Arg354Trp, p.Arg364Gln, p.Arg537Trp) reduce LPL activity in vitro, while the p.Trp464Ter nonsense variant completely abolishes LPL activity, demonstrating that pathogenic LMF1 variants impair its lipase maturation function.","method":"In vitro functional studies in HEK-293T cells co-transfected with human LPL and LMF1 cDNA constructs; LPL activity measured using human VLDL-TG as substrate","journal":"Journal of clinical lipidology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based in vitro functional assay with multiple variants tested, single lab","pmids":["30037590"],"is_preprint":false},{"year":2024,"finding":"Four homozygous LMF1 variants (p.Asn147Lys, p.Pro246Arg, p.Arg354Trp, p.Arg364Gln) reduce LPL secretion by impairing LMF1 specific activity; additionally, p.Asn147Lys also diminishes LMF1 protein expression, demonstrating that distinct molecular mechanisms underlie partial loss of LMF1 function.","method":"In vitro functional analysis in transiently transfected HEK293 cells; measurement of LPL activity, LMF1 protein expression, and LMF1 specific activity","journal":"Journal of clinical lipidology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based functional assay with multiple orthogonal measurements (activity, mass, expression), single lab","pmids":["39537501"],"is_preprint":false},{"year":2012,"finding":"LMF1 functions as an ER protein necessary for folding of LPL into its active dimeric form; its expression level in rat adipose tissue does not undergo rapid circadian or nutritional regulation (unlike ANGPTL4 and GPIHBP1), suggesting that LMF1 sets a constitutive baseline for LPL maturation capacity.","method":"Cycloheximide and actinomycin D chase experiments in rat adipose tissue; qPCR and LPL activity measurements under feeding/fasting and insulin challenge","journal":"BMC physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct biochemical measurements in animal model, single lab, limited mechanistic follow-up on LMF1 specifically","pmids":["23176178"],"is_preprint":false},{"year":2022,"finding":"In Toxoplasma gondii, an outer mitochondrial membrane-associated protein named LMF1 interacts physically with the pellicle protein IMC10 to tether the mitochondrion to the inner membrane complex (IMC); this interaction is required for correct lasso-shaped mitochondrial positioning and distribution to daughter cells during division.","method":"Yeast two-hybrid screen for LMF1 interactors; protein-protein interaction assays confirming LMF1–IMC10 interaction; conditional knockdown of IMC10 with mitochondrial morphology readout","journal":"Journal of cell science","confidence":"Low","confidence_rationale":"Tier 3 / Weak — this is a Toxoplasma gondii protein with the same name but fundamentally different function and cellular context from the mammalian lipase maturation factor; likely a symbol collision","pmids":["36314270"],"is_preprint":false}],"current_model":"LMF1 is a five-transmembrane ER-resident chaperone protein whose evolutionarily conserved DUF1222 domain physically interacts with nascent lipoprotein lipase (LPL), hepatic lipase (HL), and endothelial lipase (EL) via loop C to facilitate their post-translational folding, dimerization, and catalytic activation; loss-of-function mutations cause combined lipase deficiency and severe hypertriglyceridemia, while LMF1 expression level itself is a post-translational determinant of LPL activity, and its transcription is upregulated by ER stress through ATF6α signaling acting on a GC-rich promoter element."},"narrative":{"mechanistic_narrative":"LMF1 is an endoplasmic reticulum-resident maturation factor required for the post-translational folding and catalytic activation of secreted vascular lipases, establishing it as a central determinant of systemic triglyceride clearance [PMID:17994020, PMID:25302068]. It is a polytopic ER membrane protein with five transmembrane segments that partition it into three cytoplasmic and three ER-luminal regions; its evolutionarily conserved DUF1222 domain spans four of these segments and presents loop C, which constitutes the lipase interaction site, to the ER lumen [PMID:19783858]. Through this surface LMF1 physically engages nascent lipoprotein lipase (LPL) and hepatic lipase, and is also required for activation of endothelial lipase, folding LPL into its active dimeric form [PMID:19783858, PMID:25302068, PMID:23176178]. Beyond serving as an obligate maturation factor, the level of LMF1 expression is itself a post-translational determinant of LPL activity in vivo, as tissue-specific overexpression raises LPL activity in adipose and muscle [PMID:22345169], and its transcription is induced by ER stress via the ATF6α arm of the unfolded protein response acting on a GC-rich promoter element [PMID:25035425]. Loss-of-function mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia in mice and humans, and distinct pathogenic missense and nonsense variants impair function either by reducing LMF1 specific activity or by diminishing its protein expression [PMID:17994020, PMID:30037590, PMID:39537501].","teleology":[{"year":2007,"claim":"Established that a previously uncharacterized gene is the factor required for post-translational maturation of vascular lipases, explaining a recessive hypertriglyceridemia phenotype.","evidence":"Positional cloning of the mouse cld mutation plus identification of a deleterious human LMF1 mutation, with biochemical LPL/HL activity assays","pmids":["17994020"],"confidence":"High","gaps":["Did not define the protein's membrane topology or the physical mechanism of lipase interaction","Did not distinguish chaperone activity from a catalytic or assembly role"]},{"year":2009,"claim":"Resolved how LMF1 is organized in the ER membrane and where it contacts its client lipases, defining loop C within the conserved DUF1222 domain as the lipase interaction site.","evidence":"Transmembrane topology mapping by glycan-site insertion and GFP fusions, plus Co-IP with DUF1222 truncation variants","pmids":["19783858"],"confidence":"High","gaps":["No structural model of the LMF1–lipase complex","Mechanism by which loop C promotes folding/dimerization not resolved"]},{"year":2012,"claim":"Showed that LMF1 abundance, not just its presence, sets the ceiling on LPL activity, reframing it from an obligate switch to a dose-dependent post-translational regulator.","evidence":"aP2-Lmf1 and Mck-Lmf1 transgenic mice with tissue-specific LPL activity and mass measurements","pmids":["22345169"],"confidence":"High","gaps":["Did not address whether endogenous LMF1 levels are physiologically limiting in humans"]},{"year":2012,"claim":"Clarified the regulatory logic of LMF1 by showing it provides a constitutive baseline maturation capacity rather than acute nutritional/circadian tuning.","evidence":"Cycloheximide/actinomycin D chase and qPCR in rat adipose tissue under feeding/fasting and insulin challenge","pmids":["23176178"],"confidence":"Medium","gaps":["Limited to rat adipose tissue","No direct mechanistic follow-up on LMF1 stability or turnover"]},{"year":2014,"claim":"Linked LMF1 expression to ER stress, identifying ATF6α as the UPR transducer that drives Lmf1 transcription through a defined promoter element.","evidence":"ATF6α genetic KO and dominant-negative in MEFs/liver, tunicamycin treatment, and Lmf1 promoter luciferase reporters","pmids":["25035425"],"confidence":"High","gaps":["Physiological contexts triggering this induction in vivo not defined","Whether induced LMF1 measurably increases lipase output not quantified"]},{"year":2014,"claim":"Broadened LMF1's client repertoire to endothelial lipase and established the consequences of complete loss in a defined null model.","evidence":"LMF1-null knockout mice with LPL, HL, and EL activity assays plus expression analysis","pmids":["25302068"],"confidence":"High","gaps":["Did not determine whether all three lipases share the same loop C binding mode","Cause of neonatal lethality beyond combined lipase deficiency not dissected"]},{"year":2024,"claim":"Distinguished the molecular routes by which patient-derived LMF1 variants cause partial loss of function, separating reduced specific activity from reduced protein expression.","evidence":"In vitro functional analysis of missense and nonsense variants in HEK293/HEK-293T cells measuring LPL activity, LMF1 mass, and specific activity","pmids":["30037590","39537501"],"confidence":"Medium","gaps":["Single-lab cell-based assays without structural validation","Genotype–phenotype correlation with patient triglyceride levels not established"]},{"year":null,"claim":"The structural basis of how LMF1 loop C engages lipase clients to drive folding and dimerization, and the regulatory significance of ATF6α-driven LMF1 induction in vivo, remain open.","evidence":"","pmids":[],"confidence":"High","gaps":["No atomic-resolution structure of LMF1 or its complexes","Whether LMF1 acts catalytically or purely as a scaffold during lipase folding is unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[0,1,4]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,4]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,1,7]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,2,4]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[3]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1]}],"complexes":[],"partners":["LPL","LIPC","LIPG","ATF6"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96S06","full_name":"Lipase maturation factor 1","aliases":["Transmembrane protein 112"],"length_aa":567,"mass_kda":64.9,"function":"Involved in the maturation of specific proteins in the endoplasmic reticulum. Required for maturation and transport of active lipoprotein lipase (LPL) through the secretory pathway. Each LMF1 molecule chaperones 50 or more molecules of LPL","subcellular_location":"Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q96S06/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/LMF1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/LMF1","total_profiled":1310},"omim":[{"mim_id":"615947","title":"HYPERLIPOPROTEINEMIA, TYPE ID","url":"https://www.omim.org/entry/615947"},{"mim_id":"612757","title":"GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN 1; GPIHBP1","url":"https://www.omim.org/entry/612757"},{"mim_id":"611761","title":"LIPASE MATURATION FACTOR 1; LMF1","url":"https://www.omim.org/entry/611761"},{"mim_id":"246650","title":"LIPASE DEFICIENCY, COMBINED","url":"https://www.omim.org/entry/246650"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/LMF1"},"hgnc":{"alias_symbol":["FLJ12681","JFP11","FLJ22302","TMEM112A"],"prev_symbol":["C16orf26","TMEM112"]},"alphafold":{"accession":"Q96S06","domains":[{"cath_id":"-","chopping":"51-351_363-406","consensus_level":"medium","plddt":95.2698,"start":51,"end":406},{"cath_id":"-","chopping":"417-560","consensus_level":"high","plddt":95.566,"start":417,"end":560}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96S06","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96S06-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96S06-F1-predicted_aligned_error_v6.png","plddt_mean":90.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LMF1","jax_strain_url":"https://www.jax.org/strain/search?query=LMF1"},"sequence":{"accession":"Q96S06","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96S06.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96S06/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96S06"}},"corpus_meta":[{"pmid":"22239554","id":"PMC_22239554","title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.","date":"2012","source":"Journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22239554","citation_count":204,"is_preprint":false},{"pmid":"17994020","id":"PMC_17994020","title":"Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia.","date":"2007","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17994020","citation_count":168,"is_preprint":false},{"pmid":"23176178","id":"PMC_23176178","title":"Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue.","date":"2012","source":"BMC physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23176178","citation_count":67,"is_preprint":false},{"pmid":"19820022","id":"PMC_19820022","title":"Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.","date":"2009","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19820022","citation_count":54,"is_preprint":false},{"pmid":"36314270","id":"PMC_36314270","title":"IMC10 and LMF1 mediate mitochondrial morphology through mitochondrion-pellicle contact sites in Toxoplasma gondii.","date":"2022","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/36314270","citation_count":34,"is_preprint":false},{"pmid":"30037590","id":"PMC_30037590","title":"New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia.","date":"2018","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/30037590","citation_count":24,"is_preprint":false},{"pmid":"19783858","id":"PMC_19783858","title":"Lipase maturation factor LMF1, membrane topology and interaction with lipase proteins in the endoplasmic reticulum.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19783858","citation_count":23,"is_preprint":false},{"pmid":"30885219","id":"PMC_30885219","title":"Identification of a novel and heterozygous LMF1 nonsense mutation in an acute pancreatitis patient with severe hypertriglyceridemia, severe obesity and heavy smoking.","date":"2019","source":"Lipids in health and disease","url":"https://pubmed.ncbi.nlm.nih.gov/30885219","citation_count":21,"is_preprint":false},{"pmid":"28391895","id":"PMC_28391895","title":"Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing.","date":"2017","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/28391895","citation_count":21,"is_preprint":false},{"pmid":"22345169","id":"PMC_22345169","title":"Transgenic expression and genetic variation of Lmf1 affect LPL activity in mice and humans.","date":"2012","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22345169","citation_count":18,"is_preprint":false},{"pmid":"25035425","id":"PMC_25035425","title":"Lipase maturation factor 1 (lmf1) is induced by endoplasmic reticulum stress through activating transcription factor 6α (Atf6α) signaling.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25035425","citation_count":14,"is_preprint":false},{"pmid":"25302068","id":"PMC_25302068","title":"Embryonic viability, lipase deficiency, hypertriglyceridemia and neonatal lethality in a novel LMF1-deficient mouse model.","date":"2014","source":"Nutrition & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25302068","citation_count":12,"is_preprint":false},{"pmid":"35246399","id":"PMC_35246399","title":"Severe hypertriglyceridemia secondary to splice-site and missense variants in LMF1 in three patients from Ecuador.","date":"2022","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/35246399","citation_count":7,"is_preprint":false},{"pmid":"35368694","id":"PMC_35368694","title":"A Heterozygous LMF1 Gene Mutation (c.1523C>T), Combined With an LPL Gene Mutation (c.590G>A), Aggravates the Clinical Symptoms in Hypertriglyceridemia.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35368694","citation_count":6,"is_preprint":false},{"pmid":"33039347","id":"PMC_33039347","title":"Involvement of a homozygous exon 6 deletion of LMF1 gene in intermittent severe hypertriglyceridemia.","date":"2020","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/33039347","citation_count":6,"is_preprint":false},{"pmid":"32190547","id":"PMC_32190547","title":"Genetic and functional studies of the LMF1 gene in Thai patients with severe hypertriglyceridemia.","date":"2020","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/32190547","citation_count":5,"is_preprint":false},{"pmid":"38462482","id":"PMC_38462482","title":"Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia - Case Report and Literature Review.","date":"2024","source":"Journal of atherosclerosis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/38462482","citation_count":5,"is_preprint":false},{"pmid":"25817768","id":"PMC_25817768","title":"[Identification of variants in LMF1 gene associated with primary hypertriglyceridemia].","date":"2015","source":"Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/25817768","citation_count":5,"is_preprint":false},{"pmid":"39537501","id":"PMC_39537501","title":"Identification and functional analysis of novel homozygous LMF1 variants in severe hypertriglyceridemia.","date":"2024","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/39537501","citation_count":1,"is_preprint":false},{"pmid":"34062067","id":"PMC_34062067","title":"Assessment of Zinc- alpha2 glycoprotein (ZAG) and Lipase Maturation Factor 1 (LMF1) concentration in children with chronic kidney disease.","date":"2021","source":"Physiological research","url":"https://pubmed.ncbi.nlm.nih.gov/34062067","citation_count":1,"is_preprint":false},{"pmid":"41997320","id":"PMC_41997320","title":"Single-cell transcriptomic analysis reveals novel lncRNA macromolecules associated with PARP11, LMF1, and RRM2 regulatory axes in non-small cell lung cancer.","date":"2026","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41997320","citation_count":0,"is_preprint":false},{"pmid":"40142634","id":"PMC_40142634","title":"Identification of a Pathogenic Mutation of the Lipase Maturation Factor 1 (LMF1) Gene Causing Recurrent Pancreatitis and Requiring Critical Care.","date":"2025","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40142634","citation_count":0,"is_preprint":false},{"pmid":"41633911","id":"PMC_41633911","title":"Homozygous variant in LMF-1 identified in 3 Colombian families.","date":"2026","source":"Journal of clinical lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/41633911","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14547,"output_tokens":2501,"usd":0.040578,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9623,"output_tokens":2548,"usd":0.055907,"stage2_stop_reason":"end_turn"},"total_usd":0.096485,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"LMF1 (encoded by Tmem112/Lmf1) is required for post-translational maturation of nascent lipoprotein lipase (LPL) and hepatic lipase (HL) polypeptides in the endoplasmic reticulum; loss-of-function mutations cause combined lipase deficiency and severe hypertriglyceridemia in mice and humans.\",\n      \"method\": \"Positional cloning of the cld mutation in mice, combined with identification of a homozygous deleterious human LMF1 mutation; biochemical measurement of LPL and HL activity\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis (cld mouse) combined with human mutation identification and biochemical lipase activity assays, replicated across multiple subsequent studies\",\n      \"pmids\": [\"17994020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"LMF1 is a polytopic ER membrane protein with five transmembrane domains, dividing the protein into six domains: three cytoplasmic (N-terminal domain, loops B and D) and three ER-luminal (loops A, C, and C-terminal domain). The evolutionarily conserved DUF1222 domain spans four of these six domains with the two largest portions facing the ER lumen. LMF1 physically interacts with LPL and hepatic lipase, and the lipase interaction site was mapped to loop C within DUF1222.\",\n      \"method\": \"Transmembrane topology mapping using ectopic glycan attachment site insertions and GFP terminal fusions; co-immunoprecipitation with naturally occurring DUF1222 truncation variants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — experimental topology mapping with multiple orthogonal tagging strategies plus direct physical interaction demonstrated by Co-IP with domain truncations, single lab\",\n      \"pmids\": [\"19783858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Overexpression of Lmf1 in adipose tissue (aP2-Lmf1 transgenic mice) and muscle tissue (Mck-Lmf1 transgenic mice) increases LPL activity in vivo, establishing that variation in Lmf1 expression is a post-translational determinant of LPL activity beyond its role as a required maturation factor.\",\n      \"method\": \"Generation and characterization of aP2-Lmf1 and Mck-Lmf1 transgenic mice; measurement of LPL activity and LPL mass in relevant tissues\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean transgenic overexpression with tissue-specific LPL activity and mass measurements, two independent transgenic lines with distinct tissue outcomes\",\n      \"pmids\": [\"22345169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LMF1 expression is induced by ER stress through the ATF6α arm of the unfolded protein response (UPR). ATF6α activates the Lmf1 promoter via a GC-rich cis-regulatory element 264 bp upstream of the transcriptional start site; ATF6α deficiency (genetic ablation or dominant-negative form) abolishes tunicamycin-stimulated Lmf1 promoter activation.\",\n      \"method\": \"Genetic deficiencies in mouse embryonic fibroblasts and mouse liver; luciferase reporter constructs with the Lmf1 promoter; tunicamycin treatment; dominant-negative ATF6α expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (genetic KO, dominant-negative, reporter assay, in vivo tunicamycin model) in single lab establishing ATF6α as both sufficient and necessary\",\n      \"pmids\": [\"25035425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LMF1 is required for activation of endothelial lipase (EL) in addition to LPL and HL, demonstrating its role as a chaperone for multiple vascular lipases. LMF1-null mice are viable at birth (born at Mendelian ratios) but exhibit combined lipase deficiency, hypertriglyceridemia, and neonatal lethality.\",\n      \"method\": \"Generation and characterization of LMF1-null mice (null-allele knock-out); measurement of LPL, HL, and EL activity; qPCR and in situ hybridization\",\n      \"journal\": \"Nutrition & metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — null mouse model with direct biochemical measurements of multiple lipase activities, combined with expression analysis\",\n      \"pmids\": [\"25302068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Specific LMF1 missense variants (p.Gly172Arg, p.Arg354Trp, p.Arg364Gln, p.Arg537Trp) reduce LPL activity in vitro, while the p.Trp464Ter nonsense variant completely abolishes LPL activity, demonstrating that pathogenic LMF1 variants impair its lipase maturation function.\",\n      \"method\": \"In vitro functional studies in HEK-293T cells co-transfected with human LPL and LMF1 cDNA constructs; LPL activity measured using human VLDL-TG as substrate\",\n      \"journal\": \"Journal of clinical lipidology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based in vitro functional assay with multiple variants tested, single lab\",\n      \"pmids\": [\"30037590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Four homozygous LMF1 variants (p.Asn147Lys, p.Pro246Arg, p.Arg354Trp, p.Arg364Gln) reduce LPL secretion by impairing LMF1 specific activity; additionally, p.Asn147Lys also diminishes LMF1 protein expression, demonstrating that distinct molecular mechanisms underlie partial loss of LMF1 function.\",\n      \"method\": \"In vitro functional analysis in transiently transfected HEK293 cells; measurement of LPL activity, LMF1 protein expression, and LMF1 specific activity\",\n      \"journal\": \"Journal of clinical lipidology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based functional assay with multiple orthogonal measurements (activity, mass, expression), single lab\",\n      \"pmids\": [\"39537501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LMF1 functions as an ER protein necessary for folding of LPL into its active dimeric form; its expression level in rat adipose tissue does not undergo rapid circadian or nutritional regulation (unlike ANGPTL4 and GPIHBP1), suggesting that LMF1 sets a constitutive baseline for LPL maturation capacity.\",\n      \"method\": \"Cycloheximide and actinomycin D chase experiments in rat adipose tissue; qPCR and LPL activity measurements under feeding/fasting and insulin challenge\",\n      \"journal\": \"BMC physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct biochemical measurements in animal model, single lab, limited mechanistic follow-up on LMF1 specifically\",\n      \"pmids\": [\"23176178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In Toxoplasma gondii, an outer mitochondrial membrane-associated protein named LMF1 interacts physically with the pellicle protein IMC10 to tether the mitochondrion to the inner membrane complex (IMC); this interaction is required for correct lasso-shaped mitochondrial positioning and distribution to daughter cells during division.\",\n      \"method\": \"Yeast two-hybrid screen for LMF1 interactors; protein-protein interaction assays confirming LMF1–IMC10 interaction; conditional knockdown of IMC10 with mitochondrial morphology readout\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — this is a Toxoplasma gondii protein with the same name but fundamentally different function and cellular context from the mammalian lipase maturation factor; likely a symbol collision\",\n      \"pmids\": [\"36314270\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LMF1 is a five-transmembrane ER-resident chaperone protein whose evolutionarily conserved DUF1222 domain physically interacts with nascent lipoprotein lipase (LPL), hepatic lipase (HL), and endothelial lipase (EL) via loop C to facilitate their post-translational folding, dimerization, and catalytic activation; loss-of-function mutations cause combined lipase deficiency and severe hypertriglyceridemia, while LMF1 expression level itself is a post-translational determinant of LPL activity, and its transcription is upregulated by ER stress through ATF6α signaling acting on a GC-rich promoter element.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"LMF1 is an endoplasmic reticulum-resident maturation factor required for the post-translational folding and catalytic activation of secreted vascular lipases, establishing it as a central determinant of systemic triglyceride clearance [#0, #4]. It is a polytopic ER membrane protein with five transmembrane segments that partition it into three cytoplasmic and three ER-luminal regions; its evolutionarily conserved DUF1222 domain spans four of these segments and presents loop C, which constitutes the lipase interaction site, to the ER lumen [#1]. Through this surface LMF1 physically engages nascent lipoprotein lipase (LPL) and hepatic lipase, and is also required for activation of endothelial lipase, folding LPL into its active dimeric form [#1, #4, #7]. Beyond serving as an obligate maturation factor, the level of LMF1 expression is itself a post-translational determinant of LPL activity in vivo, as tissue-specific overexpression raises LPL activity in adipose and muscle [#2], and its transcription is induced by ER stress via the ATF6\\u03b1 arm of the unfolded protein response acting on a GC-rich promoter element [#3]. Loss-of-function mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia in mice and humans, and distinct pathogenic missense and nonsense variants impair function either by reducing LMF1 specific activity or by diminishing its protein expression [#0, #5, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Established that a previously uncharacterized gene is the factor required for post-translational maturation of vascular lipases, explaining a recessive hypertriglyceridemia phenotype.\",\n      \"evidence\": \"Positional cloning of the mouse cld mutation plus identification of a deleterious human LMF1 mutation, with biochemical LPL/HL activity assays\",\n      \"pmids\": [\"17994020\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the protein's membrane topology or the physical mechanism of lipase interaction\", \"Did not distinguish chaperone activity from a catalytic or assembly role\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Resolved how LMF1 is organized in the ER membrane and where it contacts its client lipases, defining loop C within the conserved DUF1222 domain as the lipase interaction site.\",\n      \"evidence\": \"Transmembrane topology mapping by glycan-site insertion and GFP fusions, plus Co-IP with DUF1222 truncation variants\",\n      \"pmids\": [\"19783858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of the LMF1\\u2013lipase complex\", \"Mechanism by which loop C promotes folding/dimerization not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed that LMF1 abundance, not just its presence, sets the ceiling on LPL activity, reframing it from an obligate switch to a dose-dependent post-translational regulator.\",\n      \"evidence\": \"aP2-Lmf1 and Mck-Lmf1 transgenic mice with tissue-specific LPL activity and mass measurements\",\n      \"pmids\": [\"22345169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address whether endogenous LMF1 levels are physiologically limiting in humans\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Clarified the regulatory logic of LMF1 by showing it provides a constitutive baseline maturation capacity rather than acute nutritional/circadian tuning.\",\n      \"evidence\": \"Cycloheximide/actinomycin D chase and qPCR in rat adipose tissue under feeding/fasting and insulin challenge\",\n      \"pmids\": [\"23176178\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Limited to rat adipose tissue\", \"No direct mechanistic follow-up on LMF1 stability or turnover\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked LMF1 expression to ER stress, identifying ATF6\\u03b1 as the UPR transducer that drives Lmf1 transcription through a defined promoter element.\",\n      \"evidence\": \"ATF6\\u03b1 genetic KO and dominant-negative in MEFs/liver, tunicamycin treatment, and Lmf1 promoter luciferase reporters\",\n      \"pmids\": [\"25035425\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts triggering this induction in vivo not defined\", \"Whether induced LMF1 measurably increases lipase output not quantified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Broadened LMF1's client repertoire to endothelial lipase and established the consequences of complete loss in a defined null model.\",\n      \"evidence\": \"LMF1-null knockout mice with LPL, HL, and EL activity assays plus expression analysis\",\n      \"pmids\": [\"25302068\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not determine whether all three lipases share the same loop C binding mode\", \"Cause of neonatal lethality beyond combined lipase deficiency not dissected\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Distinguished the molecular routes by which patient-derived LMF1 variants cause partial loss of function, separating reduced specific activity from reduced protein expression.\",\n      \"evidence\": \"In vitro functional analysis of missense and nonsense variants in HEK293/HEK-293T cells measuring LPL activity, LMF1 mass, and specific activity\",\n      \"pmids\": [\"30037590\", \"39537501\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab cell-based assays without structural validation\", \"Genotype\\u2013phenotype correlation with patient triglyceride levels not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of how LMF1 loop C engages lipase clients to drive folding and dimerization, and the regulatory significance of ATF6\\u03b1-driven LMF1 induction in vivo, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution structure of LMF1 or its complexes\", \"Whether LMF1 acts catalytically or purely as a scaffold during lipase folding is unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 1, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"LPL\", \"LIPC\", \"LIPG\", \"ATF6\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}